What's happening
The bill requires the health equity council to issue mandates improving sickle cell disease treatment and care, including education, data collection, and specialized centers.
Why it matters
Mandates, not just recommendations, will now be required from the health equity council, giving their guidance on sickle cell disease treatment real authority and ensuring implementation by the Health Department.
The bill requires the creation of regional sickle cell centers, meaning more coordinated, specialized care—including pain management, mental health, trait testing, and genetic counseling—will be available closer to patients throughout the state.
Long-term surveillance and data collection on sickle cell complications, mortality, health services use, and costs will be mandated, providing critical information to identify at-risk populations and respond to emerging health trends.
Workforce development will be mandated in both primary and specialty care, aiming to ensure more healthcare professionals are trained to recognize, manage, and treat sickle cell disease effectively.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Health Equity Council and state health commissioner
The bill would require the council to issue sickle cell mandates regardless of its feasibility findings and require the commissioner to act on the council’s advice, recommendations and mandates.
People with sickle cell disease
Mandates would include regional centers providing integrated care, including pain management, mental health services, trait testing and genetic counseling, and long-term tracking of disease complications and care.
Primary and specialty care professionals
The council would have to mandate sickle cell workforce development and education programs covering early detection, screening and best practices.
Organizations approved for grants and underserved populations
Mandates would include grants to approved organizations and a statewide education and outreach campaign that specifically reaches underserved populations.
Headline styles
Mandate Sickle Cell Treatment
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8924
IN SENATE
March 28, 2024
Introduced by Sen. PARKER -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to requiring the health equity council to issue mandates related to the treatment of sickle cell disease
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph c of subdivision 6 of section 243 of the public health law, as added by chapter 684 of the laws of 2023, is amended to read as follows:
c. The council shall consider the feasibility of the following, and notwithstanding the findings, shall issue mandates to the commissioner for:
(i) the establishment of a statewide public education and outreach campaign to publicize evidence based sickle cell disease screening, detection and education services. The campaign shall include: general community education, outreach to specific underserved populations, evidence based clinical sickle cell disease screening services, and an informational summary that shall include an explanation of the importance of clinical examinations and what to expect during clinical examinations and sickle cell disease screening services;
(ii) the provision of grants to approved organizations;
(iii) the compilation of data concerning sickle cell disease and dissemination of such data to the public; [and]
(iv) the development of health care professional education programs including the benefits of early detection of sickle cell disease and clinical examinations, the recommended frequency of clinical examinations and sickle cell disease screening services, and professionally recognized best practices guidelines;
(v) the establishment of regional sickle cell centers to provide teambased, integrated care including pain management, mental health, trait testing, and genetic counseling;
(vi) the implementation of workforce development in primary and specialty care with a focus on sickle cell disease; and
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15055-01-4
(vii) the support of long-term surveillance of sickle cell disease complications, mortality, health services utilization, and cost throughout the lifespan of sickle cell disease patients to understand which populations are most vulnerable and identify emerging trends for action.
§ 2. Subdivision 1 of section 206 of the public health law is amended by adding a new paragraph (w) to read as follows:
(w) consider, adhere to, and act upon all advice, recommendations and mandates provided by the health equity council pursuant to subdivision six of section two hundred forty-three of this chapter.
§ 3. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to requiring the health equity council to issue mandates related to the treatment of sickle cell disease
Purpose or general idea of bill
This bill requires the health equity council to issue mandates to the commissioner of the health department for the establishment of regional sickle cell centers; the implementation of workfOrce development in primary and specialty care with a focus on sickle cell disease; and the support of long-term surveillance of sickle cell disease complications, mortality, health services utilization, and cost throughout the lifespan of sickle cell disease patients.
Summary of specific provisions
Section 1 amends paragraph c of subdivision 6 of section 243 of the public health law.
Section 2 amends subdivision 1 of section 206 of the public health law.
Section 3 sets forth the effective date.
Justification
The establishment of regional sickle cell disease (SCD) centers is a critical step towards addressing the complex needs of individuals with sickle cell disease. These centers will serve as hubs for team-based integrated care, providing comprehensive services that are essential for improving patient outcomes and quality of life. Sickle cell disease patients require multifaceted care that addresses not only their phys- ical symptoms but also their mental health needs. Integrated care centers can provide pain management, mental health services, trait test- ing, and genetic counseling, ensuring a holistic approach to patient care.
Sickle cell disease predominantly affects minority groups, who histor- ically have had less access to comprehensive care. Establishing regional centers is a step towards rectifying health disparities and promoting equity in healthcare access and outcomes. By centralizing resources and expertise, regional sickle cell centers can reduce the overall cost burden on the healthcare system through more efficient management of sickle cell disease.
There is a pressing need for specialized training in SCD care within both primary and specialty care settings. By implementing workforce development programs, healthcare professionals can be better equipped to meet the unique challenges of treating SCD. The chronic nature of SCD necessitates ongoing monitoring to track disease complications, mortal- ity rates, health services utilization, and associated costs. Long-term surveillance will help identify at-risk populations and emerging trends, enabling proactive and targeted interventions.
Prior legislative history
New Bill.
Fiscal implications
EFFECTIVE DATE: This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.